HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cosmetic Talc Under Scrutiny As Liability Buzzards Circle

This article was originally published in The Rose Sheet

Executive Summary

Plaintiff’s attorneys are tracking reports of asbestos-contaminated cosmetics at specialty retail stores, signaling a possible new wave of talc-related litigation to come. The issue also has the attention of NGOs, legislators and FDA.

You may also be interested in...



FDA’s Cosmetics Manufacturing Survey Under Way; J&J, Colgate Jointly Defending Talc In California; News In Brief

FDA moves ahead with its plan to survey the cosmetics industry on current manufacturing practices, with 900 companies selected for invitations to participate. More cosmetics news in brief.

J&J To Appeal $37M Mesothelioma Verdict, A First In Talc Trials

The mesothelioma liability case marks the first in New Jersey, the first involving a male plaintiff and the first to result in a plaintiff verdict. Punitive damages, potentially on top of the $37m in compensatory damages, have yet to be decided in the matter linking J&J’s talc to asbestos dangers.

‘Asbestos-Free’ A Relative Term? SAI Testing Expert On Cosmetic Talc Challenges

Transmission electron microscopy is likely the safest bet, among other imaging technologies, for companies looking to verify their cosmetic talc as asbestos-free. However, there’s no regulatory-mandated method for cosmetics purposes, which may explain conflicting results being reported by different labs.  

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121520

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel